BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 26122702)

  • 21. Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosis.
    Martin IV; Borkham-Kamphorst E; Zok S; van Roeyen CR; Eriksson U; Boor P; Hittatiya K; Fischer HP; Wasmuth HE; Weiskirchen R; Eitner F; Floege J; Ostendorf T
    Am J Pathol; 2013 Jan; 182(1):107-17. PubMed ID: 23141925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective deletion of hepatocyte platelet-derived growth factor receptor α and development of liver fibrosis in mice.
    Lim BJ; Lee WK; Lee HW; Lee KS; Kim JK; Chang HY; Lee JI
    Cell Commun Signal; 2018 Dec; 16(1):93. PubMed ID: 30509307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-β1 and TGF-β2 abundance in liver diseases of mice and men.
    Dropmann A; Dediulia T; Breitkopf-Heinlein K; Korhonen H; Janicot M; Weber SN; Thomas M; Piiper A; Bertran E; Fabregat I; Abshagen K; Hess J; Angel P; Coulouarn C; Dooley S; Meindl-Beinker NM
    Oncotarget; 2016 Apr; 7(15):19499-518. PubMed ID: 26799667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a novel TGF-β-miR-122-fibronectin 1/serum response factor signaling cascade and its implication in hepatic fibrogenesis.
    Zeng C; Wang YL; Xie C; Sang Y; Li TJ; Zhang M; Wang R; Zhang Q; Zheng L; Zhuang SM
    Oncotarget; 2015 May; 6(14):12224-33. PubMed ID: 25909171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice.
    Matsumoto Y; Itami S; Kuroda M; Yoshizato K; Kawada N; Murakami Y
    Mol Ther; 2016 Oct; 24(10):1848-1859. PubMed ID: 27480597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.
    Yang X; Zhang XF; Lu X; Jia HL; Liang L; Dong QZ; Ye QH; Qin LX
    Hepatology; 2014 May; 59(5):1874-85. PubMed ID: 24259426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative regulation of the hepatic fibrogenic response by suppressor of cytokine signaling 1.
    Kandhi R; Bobbala D; Yeganeh M; Mayhue M; Menendez A; Ilangumaran S
    Cytokine; 2016 Jun; 82():58-69. PubMed ID: 26748724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties.
    He XX; Guo AY; Xu CR; Chang Y; Xiang GY; Gong J; Dan ZL; Tian DA; Liao JZ; Lin JS
    Oncol Rep; 2014 Sep; 32(3):1200-10. PubMed ID: 24993451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver.
    Elmén J; Lindow M; Silahtaroglu A; Bak M; Christensen M; Lind-Thomsen A; Hedtjärn M; Hansen JB; Hansen HF; Straarup EM; McCullagh K; Kearney P; Kauppinen S
    Nucleic Acids Res; 2008 Mar; 36(4):1153-62. PubMed ID: 18158304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.
    Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
    Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [MicroRNAs in hepatocarcinogenesis].
    Lendvai G; Kiss A; Kovalszky I; Schaff Z
    Orv Hetil; 2012 Jun; 153(25):978-89. PubMed ID: 22714032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H; Ooi LL; Hui KM
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats.
    Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK
    J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transforming growth factor-β1 small interfering RNA regulates platelet-derived growth factor and phosphorylated extracellular regulated protein kinase in rats with hepatic fibrosis: an experimental study].
    Zhou XF; Jiang YJ; Zhang Y; Sun H; Liu Q; Shi XF
    Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):701-705. PubMed ID: 29108193
    [No Abstract]   [Full Text] [Related]  

  • 38. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway.
    Zhang T; Hu J; Wang X; Zhao X; Li Z; Niu J; Steer CJ; Zheng G; Song G
    J Hepatol; 2019 Jan; 70(1):87-96. PubMed ID: 30218679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production.
    Ogata H; Chinen T; Yoshida T; Kinjyo I; Takaesu G; Shiraishi H; Iida M; Kobayashi T; Yoshimura A
    Oncogene; 2006 Apr; 25(17):2520-30. PubMed ID: 16474852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice.
    Czochra P; Klopcic B; Meyer E; Herkel J; Garcia-Lazaro JF; Thieringer F; Schirmacher P; Biesterfeld S; Galle PR; Lohse AW; Kanzler S
    J Hepatol; 2006 Sep; 45(3):419-28. PubMed ID: 16842882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.